Combining SAA and ESR, as well as other inflammatory markers, as diagnostic and follow-up tools for inflammation has potential value, especially if therapeutic interventions targeting chronic inflammation can be integrated into the comprehensive CKD treatment strategy. Here, ESR1 is linked to chronic kidney disease.